临床和实验医学杂志2024,Vol.23Issue(5) :489-493.DOI:10.3969/j.issn.1671-4695.2024.05.011

中性粒细胞与淋巴细胞比值和嗜酸性粒细胞对AECOPD患者出院后1年内COPD相关再入院的预测价值

Predictive value of neutrophil-to-lymphocyte ratio and eosinophil on COPD related readmission within 1 year after discharge in pa-tients with AECOPD

刘雪 韩明锋 谢猛 张梦娜
临床和实验医学杂志2024,Vol.23Issue(5) :489-493.DOI:10.3969/j.issn.1671-4695.2024.05.011

中性粒细胞与淋巴细胞比值和嗜酸性粒细胞对AECOPD患者出院后1年内COPD相关再入院的预测价值

Predictive value of neutrophil-to-lymphocyte ratio and eosinophil on COPD related readmission within 1 year after discharge in pa-tients with AECOPD

刘雪 1韩明锋 2谢猛 1张梦娜1
扫码查看

作者信息

  • 1. 阜阳市第二人民医院全科医学科 安徽 阜阳 236000
  • 2. 阜阳市第二人民医院呼吸内科 安徽 阜阳 236000
  • 折叠

摘要

目的 探究中性粒细胞/淋巴细胞比率(NLR)和嗜酸性粒细胞计数(EOS)对慢性阻塞性肺疾病急性加重期(AECOPD)患者出院后1年内慢性阻塞性肺疾病(COPD)相关再入院的预测价值.方法 将2020年12月至2022年6月阜阳市第二人民医院收治的100例AECOPD患者纳入本次回顾性研究,将出院后1年内有≥1次再入院记录的患者纳入再入院组(n=35),其他患者纳入非再入院组(n=65).比较两组的临床资料(包括一般资料、实验室检查资料、治疗方法和死亡情况).根据NLR、EOS的预测AECOPD再入院的受试者工作特征(ROC)曲线截断值将患者分组,分别为高NLR组(n=43)和低NLR组(n=57)、低EOS组(n=51)和高EOS组(n=49).比较各组的住院时间、1年内COPD相关再入院情况和死亡情况,采用Logistic回归分析NLR、EOS预测AECOPD再入院的风险.结果 再入院组患者住院时间为(16.68±6.44)d,明显长于非再入院组[(14.02±6.26)d],全身糖皮质激素使用患者比率为28.57%,明显少于非再入院组(53.85%),NLR为8.57±3.16,显著低于非再入院组(13.97±3.79),EOS为(0.25±0.07)× 109/L,显著高于非再入院组[(0.12±0.06)× 109/L],差异均有统计学意义(P<0.05).低NLR组1年内COPD相关再入院次数和人数占比分别为(1.32±0.34)次、46.51%,均高于高NLR组[(0.83±0.31)次、26.32%],差异均有统计学意义(P<0.05).高EOS组1年内COPD相关再入院次数和人数占比分别为(1.35±0.40)次、44.90%,均高于低EOS组[(0.81±0.37)次、25.49%],差异均有统计学意义(P<0.05).Logistic回归分析显示,低NLR(<4.85)与高EOS(≥0.1 × 109/L)与 1年内 COPD 相关的再入院风险相关[OR=4.394(95%CI:1.152~8.203);OR=4.699(95%CI:1.152~8.583)].结论 入院时的NLR和EOS可能与AECOPD患者出院后1年内COPD相关再入院有关,可作为预测出院后再住院的生物标志物.

Abstract

Objective To investigate the predictive value of neutrophil-lymphocyte ratio(NLR)and eosinophil count(EOS)on chron-ic obstructive pulmonary disease(COPD)related readmission within 1 year after discharge in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods A total of 100 AECOPD patients admitted to the Second Peoples Hospital of Fuyang City from Decem-ber 2020 to June 2022 were included in this retrospective study.Patients with one or more readmission record within one year after discharge were included in the readmission group(n=35),and other patients were included in the non-readmission group(n=65).Clinical data(including general information,laboratory test data,treatment methods,and mortality status)of the two groups were compared.Patients were divided into the high NLR group(n=43)and the low NLR group(n=57),the low EOS group(n=51),and the high EOS group(n=49)according to the cut-off values of receiver operating characteristic(ROC)curves for predicting readmission of AECOPD using NLR and EOS.The hospital stay,COPD related readmission within 1 year and mortality were compared.Logistic regression analysis was conducted to assess the risk of read-mission for AECOPD using NLR and EOS as predictors.Results The hospital stay of patients in the readmission group was(16.68±6.44)days,which was significantly longer than that in the non readmission group[(14.02±6.26)days],the proportion of patients receiving systemic glucocorticoids was 28.57%,which was significantly lower than that in the non readmission group(53.85%),the NLR was 8.57±3.16,which was significantly lower than that in the non readmission group(13.97±3.79),and the EOS was(0.25±0.07)×109/L,which was significantly higher than that in the non readmission group[(0.12±0.06)× 109/L],the differences were statistically significant(P<0.05).The frequen-cy and proportion of COPD related readmissions within 1 year in the low NLR group were(1.32±0.34)and 46.51%,respectively,which were higher than those in the high NLR group[(0.83±0.31)and 26.32%],the differences were statistically significant(P<0.05).The number and proportion of COPD related readmission within 1 year in the high EOS group were(1.35±0.40)and 44.90%,respectively,which were higher than those in the low EOS group[(0.81±0.37)and 25.49%],the differences were statistically significant(P<0.05).Logistic regres-sion analysis showed that low NLR(<4.85)and high EOS(≥0.1 × 109/L)was associated with the risk of readmission related to COPD within 1 year[OR=4.394(95%CI:1.152-8.203);OR=4.699(95%CI:1.152-8.583)].Conclusion NLR and EOS at admission may be related to COPD related readmission within 1 year after discharge,and can be considered as biomarkers for predicting readmission rates after discharge.

关键词

中性粒细胞与淋巴细胞比值/嗜酸性粒细胞/慢性阻塞性肺病/急性加重期/再入院

Key words

Neutrophil to lymphocyte ratio/Eosinophil/Chronic obstructive pulmonary disease/Acute exacerbation period/Readmission

引用本文复制引用

基金项目

安徽省科技发展计划(2021H020154)

出版年

2024
临床和实验医学杂志
首都医科大学附属北京友谊医院

临床和实验医学杂志

CSTPCD
影响因子:1.504
ISSN:1671-4695
参考文献量23
段落导航相关论文